PCRX
Pacira Biosciences Inc
NASDAQ · Pharmaceuticals
$21.00
+0.64 (+3.14%)
Open$20.61
Previous Close$20.36
Day High$21.07
Day Low$20.44
52W High$27.64
52W Low$18.80
Volume—
Avg Volume698.9K
Market Cap903.45M
P/E Ratio42.14
EPS$0.47
SectorPharmaceuticals
Analyst Ratings
Buy
13 analysts
Price Target
+8.1% upside
Current
$21.00
$21.00
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 652.10M | 598.37M | 215.89M |
| Net Income | -92,620,505 | -76,489,681 | 44.13M |
| Profit Margin | -14.2% | -13.5% | 20.4% |
| EBITDA | -8,316,012 | -7,249,230 | 73.70M |
| Free Cash Flow | — | — | 36.97M |
| Rev Growth | +9.0% | +9.0% | -9.0% |
| Debt/Equity | 0.75 | 0.75 | 0.86 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |